Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases

Autores
del Carmen, Silvina Andrea; de Moreno, Maria Alejandra; Miyoshi, Anderson; Santos Rocha, Clarissa; Azevedo, Vasco; Leblanc, Jean Guy Joseph
Año de publicación
2011
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally present in many foods and possess a wide range of therapeutic properties. The aim of this paper is to present an overview of the current expanding knowledge of the mechanisms by which LAB and other probiotic microorganisms participate in the prevention and treatment of inflammatory bowel diseases. These include changes in the gut microbiota, stimulation of the host immune responses, and reduction of the oxidative stress due to their antioxidant properties. A brief overview of the uses of genetically engineered LAB that produce either antioxidant enzymes (such as catalase and superoxide dismutase) or anti-inflammatory cytokines (such as IL-10) will also be discussed. This paper will show that probiotics should be considered in treatment protocols of IBD since they provide many beneficial effects and can enhance the effectiveness of traditional used medicines.
Fil: del Carmen, Silvina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: de Moreno, Maria Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Miyoshi, Anderson. Universidade Federal de Minas Gerais; Brasil
Fil: Santos Rocha, Clarissa. Universidade Federal de Minas Gerais; Brasil
Fil: Azevedo, Vasco. Universidade Federal de Minas Gerais; Brasil
Fil: Leblanc, Jean Guy Joseph. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Materia
PROBIOTICS
INFLAMMATORY BOWEL DISEASE
LACTIC ACID BACTERIA
ANTIOXIDANT
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/58542
Acceder
id CONICETDig_48e9deb0d1826b45030bbbe33915b2b5
oai_identifier_str oai:ri.conicet.gov.ar:11336/58542
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseasesdel Carmen, Silvina Andreade Moreno, Maria AlejandraMiyoshi, AndersonSantos Rocha, ClarissaAzevedo, VascoLeblanc, Jean Guy JosephPROBIOTICSINFLAMMATORY BOWEL DISEASELACTIC ACID BACTERIAANTIOXIDANThttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally present in many foods and possess a wide range of therapeutic properties. The aim of this paper is to present an overview of the current expanding knowledge of the mechanisms by which LAB and other probiotic microorganisms participate in the prevention and treatment of inflammatory bowel diseases. These include changes in the gut microbiota, stimulation of the host immune responses, and reduction of the oxidative stress due to their antioxidant properties. A brief overview of the uses of genetically engineered LAB that produce either antioxidant enzymes (such as catalase and superoxide dismutase) or anti-inflammatory cytokines (such as IL-10) will also be discussed. This paper will show that probiotics should be considered in treatment protocols of IBD since they provide many beneficial effects and can enhance the effectiveness of traditional used medicines.Fil: del Carmen, Silvina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: de Moreno, Maria Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Miyoshi, Anderson. Universidade Federal de Minas Gerais; BrasilFil: Santos Rocha, Clarissa. Universidade Federal de Minas Gerais; BrasilFil: Azevedo, Vasco. Universidade Federal de Minas Gerais; BrasilFil: Leblanc, Jean Guy Joseph. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaHindawi Publishing Corporation2011-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/58542del Carmen, Silvina Andrea; de Moreno, Maria Alejandra; Miyoshi, Anderson; Santos Rocha, Clarissa; Azevedo, Vasco; et al.; Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases; Hindawi Publishing Corporation; Ulcers; 2011; 841651; 1-2011; 1-132090-1526CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1155/2011/841651info:eu-repo/semantics/altIdentifier/url/https://www.hindawi.com/journals/ulcers/2011/841651/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:48:12Zoai:ri.conicet.gov.ar:11336/58542instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:48:13.158CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
title Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
spellingShingle Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
del Carmen, Silvina Andrea
PROBIOTICS
INFLAMMATORY BOWEL DISEASE
LACTIC ACID BACTERIA
ANTIOXIDANT
title_short Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
title_full Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
title_fullStr Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
title_full_unstemmed Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
title_sort Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
dc.creator.none.fl_str_mv del Carmen, Silvina Andrea
de Moreno, Maria Alejandra
Miyoshi, Anderson
Santos Rocha, Clarissa
Azevedo, Vasco
Leblanc, Jean Guy Joseph
author del Carmen, Silvina Andrea
author_facet del Carmen, Silvina Andrea
de Moreno, Maria Alejandra
Miyoshi, Anderson
Santos Rocha, Clarissa
Azevedo, Vasco
Leblanc, Jean Guy Joseph
author_role author
author2 de Moreno, Maria Alejandra
Miyoshi, Anderson
Santos Rocha, Clarissa
Azevedo, Vasco
Leblanc, Jean Guy Joseph
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv PROBIOTICS
INFLAMMATORY BOWEL DISEASE
LACTIC ACID BACTERIA
ANTIOXIDANT
topic PROBIOTICS
INFLAMMATORY BOWEL DISEASE
LACTIC ACID BACTERIA
ANTIOXIDANT
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally present in many foods and possess a wide range of therapeutic properties. The aim of this paper is to present an overview of the current expanding knowledge of the mechanisms by which LAB and other probiotic microorganisms participate in the prevention and treatment of inflammatory bowel diseases. These include changes in the gut microbiota, stimulation of the host immune responses, and reduction of the oxidative stress due to their antioxidant properties. A brief overview of the uses of genetically engineered LAB that produce either antioxidant enzymes (such as catalase and superoxide dismutase) or anti-inflammatory cytokines (such as IL-10) will also be discussed. This paper will show that probiotics should be considered in treatment protocols of IBD since they provide many beneficial effects and can enhance the effectiveness of traditional used medicines.
Fil: del Carmen, Silvina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: de Moreno, Maria Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Miyoshi, Anderson. Universidade Federal de Minas Gerais; Brasil
Fil: Santos Rocha, Clarissa. Universidade Federal de Minas Gerais; Brasil
Fil: Azevedo, Vasco. Universidade Federal de Minas Gerais; Brasil
Fil: Leblanc, Jean Guy Joseph. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
description Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally present in many foods and possess a wide range of therapeutic properties. The aim of this paper is to present an overview of the current expanding knowledge of the mechanisms by which LAB and other probiotic microorganisms participate in the prevention and treatment of inflammatory bowel diseases. These include changes in the gut microbiota, stimulation of the host immune responses, and reduction of the oxidative stress due to their antioxidant properties. A brief overview of the uses of genetically engineered LAB that produce either antioxidant enzymes (such as catalase and superoxide dismutase) or anti-inflammatory cytokines (such as IL-10) will also be discussed. This paper will show that probiotics should be considered in treatment protocols of IBD since they provide many beneficial effects and can enhance the effectiveness of traditional used medicines.
publishDate 2011
dc.date.none.fl_str_mv 2011-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/58542
del Carmen, Silvina Andrea; de Moreno, Maria Alejandra; Miyoshi, Anderson; Santos Rocha, Clarissa; Azevedo, Vasco; et al.; Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases; Hindawi Publishing Corporation; Ulcers; 2011; 841651; 1-2011; 1-13
2090-1526
CONICET Digital
CONICET
url http://hdl.handle.net/11336/58542
identifier_str_mv del Carmen, Silvina Andrea; de Moreno, Maria Alejandra; Miyoshi, Anderson; Santos Rocha, Clarissa; Azevedo, Vasco; et al.; Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases; Hindawi Publishing Corporation; Ulcers; 2011; 841651; 1-2011; 1-13
2090-1526
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1155/2011/841651
info:eu-repo/semantics/altIdentifier/url/https://www.hindawi.com/journals/ulcers/2011/841651/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Hindawi Publishing Corporation
publisher.none.fl_str_mv Hindawi Publishing Corporation
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268910464794624
score 13.13397

Publicaciones similares